Podcasts about Seldin

https://www.hackyourfuture.net Connect with Stas Seldin: https://www.linkedin.com/in/stasel Connect with Utku K.: https://www.linkedin.com/in/uk748392 Full episode on YouTube ▶️ https://youtu.be/ejgyef9PM4o Beyond Coding Podcast with ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

ICYMI: Hour Three of ‘Later, with Mo'Kelly' Presents – An in-depth conversation with Comic Con Revolution CEO Drew Seldin, who returns to the program with a preview the Inland Empire's only full scale comic & pop culture experience, taking place THIS weekend at the Ontario Convention Center (May 18-19); featuring an amazing guest line-up of  comic book legends, artists & writers, film & TV stars, voice actors, cosplayers and so much more - on KFI AM 640…Live everywhere on the iHeartRadio app

ICYMI: ‘Later, with Mo'Kelly' Presents – An in-depth conversation with Comic Con Revolution CEO Drew Seldin, who returns to the program with a preview the Inland Empire's only full scale comic & pop culture experience, taking place THIS weekend at the Ontario Convention Center (May 18-19); featuring an amazing guest line-up of  comic book legends, artists & writers, film & TV stars, voice actors, cosplayers and so much more - on KFI AM 640…Live everywhere on the iHeartRadio app

Stormin' Norman Seldin's musical odyssey is a testament to the transformative power of passion and perseverance. From humble beginnings in bars and juke joints to commanding stages at Madison Square Garden and even gracing the halls of the White House, Seldin's trajectory is nothing short of remarkable.At the heart of his artistry lies a fusion of American Roots music and classical finesse, nurtured since childhood with early piano lessons at Manhattan School. Credited as a pioneer of the legendary Sound of Asbury Park, Seldin's innovative blend of Rhythm and Blues, Rock, Pop, Doo-Wop, and Jazz defined an era and birthed a musical movement along the Jersey Shore in the '60s.Today, Seldin stands tall as one of Steinway's esteemed Artists in Residence, a testament to his unparalleled skill and dedication. With his official biography, "You Don't Know Me," penned by historian Charlie Horner, offering insights into his extraordinary journey, and an upcoming album promising fresh musical delights, Stormin' Norman continues to enchant audiences and inspire generations with his timeless artistry. Stormin Norman Seldin is truly Someone You Should Know. Tip Jar:Click here to buy the Rik Anthony a cold one.Show Links:Click here to go to Norman's WebsiteClick here to go to Norman's FacebookClick here to purchase Norman's BookNorman's Email is normanseldin@aol.comTo purchase a vinyl copy of A Timeless Memory call 732-245-4777All music used by permission from the artistSomeone You Should Know 2024 // CatGotYourTongueStudios 2024How to Contact Us:Official Website: https://Someoneyoushouldknowpodcast.comGmail: Someoneyoushouldknowpodcast@gmail.comTwitter: @RIKANTHONY1Facebook: https://www.facebook.com/rikanthonyInstagram: https://www.instagram.com/someoneyoushouldknowpodcast/LinkedIn: https://www.linkedin.com/in/rik-anthony2019/TikTok: @SomeoneYouShouldKnow2023YouTube: https://www.youtube.com/@someoneyoushouldknowpodcastThank you for listening!Theme music "Welcome to the Show" by Kevin MacLeod was used per the standard license agreement.

Con season is definitely upon us and Geekscape is back with a whole Fallout vault's worth of news, reviews, and guest conversation! This week, Comic Revolution's own Drew Seldin joins us to talk about the upcoming best-kept-secret comic convention in Southern California! This year's lineup is awesome with the c voice cast of X-Men '97, Freddie Prinze Jr., Rachel Lee Cook, Jimmy Palmiotti, Amanda Conner, legendary Star Wars writer Timothy Zahn, Samoa Joe, and more! Joining us is Josh Jackson from Geekscape's own Dynamic Resolutions podcast as we discuss the new 'Fallout' and 'Shogun' TV shows, 'X-Men '97', 'Godzilla x Kong: The New Empire and so much more! Learn more about Comic Con Revolution right here! You can also subscribe to the Geekscape podcast on Spotify: https://spoti.fi/3H27uMH Apple Podcasts: https://apple.co/3BVrnkW Learn more about your ad choices. Visit megaphone.fm/adchoices

It was a win-win solution, hiding in plain sight. Community colleges could serve more parents with young children if parents had easier access to affordable childcare. Head Start Centers, for their part, want to serve more families. Idea: If more community colleges could host Head Start Centers right on their campuses, eligible parents would have immediate access to free child care, colleges could better tap into a population of potential students, and Head Start centers could get free space and access to aspiring teachers. Abigail Seldin, founder of the Seldin/Haring-Smith Foundation, did what leanly staffed foundations are perfectly positioned to do - she saw the potential of a great idea and took the initiative to act on it. Abigail brought together the Association of Community College Trustees and the National Head Start Association, and engaged another small funder, the ECMC Foundation, to provide a modest but critical grant to design ways for more Head Start Centers to locate to community college campuses. The idea is already attracting enthusiastic support from community colleges, Head Start programs, Federal Government agencies, and other potential partners. In this podcast, Abigail explores how the idea and vision emerged, and the steps her small foundation took to help make it a reality.  *** Abigail Seldin is CEO of the Seldin/Haring-Smith Foundation (SHSF). Under her leadership, SHSF seeded Kids on Campus, a new effort with the National Head Start Association and Association of Community College Trustees to relocate Head Start centers to community college campuses. At SHSF, Abigail also launched a partnership with Getty Images to create new stock photos of today's college students and published new data on transit inaccessibility that has generated bipartisan legislation. Abigail co-founded and sold a tech start-up and studied at Oxford as a Rhodes Scholar.

It was a win-win solution, hiding in plain sight. Community colleges could serve more parents with young children, if parents had easier access to affordable childcare. Head Start Centers, for their part, want to serve more families. Idea: If more community colleges could host Head Start Centers right on their campuses, eligible parents would have immediate access to free child care, colleges could better tap into a population of potential students, and Head Start centers could get free space and access to aspiring teachers. Abigail Seldin, founder of the Seldin/Haring-Smith Foundation, did what leanly staffed foundations are perfectly positioned to do - she saw the potential of a great idea, and took the initiative to act on it. Abigail brought together the Association of Community College Trustees and the National Head Start Association, and engaged another small funder, the ECMC Foundation, to provide a modest but critical grant to design ways for more Head Start Centers to locate to community college campuses. The idea is already attracting enthusiastic support from community colleges, Head Start programs, Federal Government agencies, and other potential partners. In this podcast, Abigail explores how the idea and vision emerged, and the steps her small foundation took to help make it a reality.  *** Abigail Seldin is CEO of the Seldin/Haring-Smith Foundation (SHSF). Under her leadership, SHSF seeded Kids on Campus, a new effort with the National Head Start Association and Association of Community College Trustees to relocate Head Start centers to community college campuses. At SHSF, Abigail also launched a partnership with Getty Images to create new stock photos of today's college students and published new data on transit inaccessibility that has generated bipartisan legislation. Abigail co-founded and sold a tech start-up and studied at Oxford as a Rhodes Scholar.

"The idea of competing as a way of trying to motivate people to learn is really silly because learning is hard-wired into human beings." - Tim Seldin, President of The Montessori Foundation. Join us today as we dive into the world of education and teaching with our esteemed guest, Tim Seldin, President of The Montessori Foundation. Discover the power of the Montessori approach to education, its impact on early childhood development, and how it extends beyond classrooms to shape civic life and government. Whether you're a parent, educator, or simply curious about effective learning strategies, this episode is a must-watch! Tune in now to the School Success Podcast and be inspired by Tim Seldin's wisdom. Don't forget to like, subscribe, and share with your friends!  #SchoolSuccess #SchoolSuccessMakers --  Today's episode is sponsored by America's Christian Credit Union. With over 65 years of experience serving Christians across the country, they offer banking services and tuition financing programs for schools. If you're a private school looking to reduce your risk and administrative burden, America's Christian Credit Union offers tuition financing plans for families. Visit ⁠⁠⁠⁠⁠⁠⁠americaschristiancu.com⁠⁠⁠⁠⁠⁠⁠ to learn more. Every week on The School Success Podcast, digital marketing agency owner Mitchell Slater interviews school leaders and game-changers in the education sector. Never miss an episode and follow The School Success Podcast on Apple Podcasts, Spotify, Stitcher, or wherever you enjoy podcasts. This podcast is powered by Slater Strategies, a marketing agency committed to helping schools grow their enrollment and connect better with the families in their communities. Find out more at ⁠⁠⁠⁠⁠⁠⁠https://schoolsuccessmakers.com⁠⁠⁠⁠⁠⁠⁠. Highlights of the Episode: [02:06] My mother founded a Montessori school in Washington, DC in 1932 [03:34] Montessori is a way of organizing organizations, families [05:40] Learning is hard-wired into human beings [06:21] I wrote a book called How To Raise An Amazing Child [08:47] Children want to be independent. [09:39] Children are capable of amazing things [12:38] Our argument is don't fight human nature [20:43] Every kid's a little different. [21:33] We really want to get kids into school...not preschool [32:39] Montessori was a scientist and...was trying to figure out how kids learn best. [37:51] Stop thinking of a school as a factory, stop thinking of it as a prison [41:52] A Worldwide Movement YouTube Video Podcast Link:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://youtu.be/WLwOlTjydFg

ICYMI: Later, with Mo'Kelly Presents – An in-depth conversation with Drew Seldin, the Co-Founder and Co-Owner of Comic Con Revolution; the Southland's largest, family-friendly comic and pop culture convention and Expo, for comic book and entertainment enthusiasts - on KFI AM 640 – Live everywhere on the iHeartRadio app

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.01.25.525595v1?rss=1 Authors: Massa, M. G., Scott, R. L., Cara, A. L., Cortes, L. R., Sandoval, N. P., Park, J. W., Ali, S., Velez, L., Tesfaye, B., Reue, K., van Veen, J. E., Seldin, M. M., Correa, S. M. Abstract: Trade-offs between metabolic and reproductive processes are important for survival, particularly in mammals that gestate they're young. Puberty and reproduction, as energetically taxing life stages, are often gated by metabolic availability in animals with ovaries. How the nervous system coordinates these trade-offs is an active area of study. We identify somatostatin neurons of the tuberal nucleus (TNSST) as a node of the feeding circuit that alters feeding in a manner sensitive to metabolic and reproductive states in mice. Whereas chemogenetic activation of TNSST neurons increased food intake across sexes, selective ablation decreased food intake only in female mice during proestrus. Interestingly, this ablation effect was only apparent in animals with a low body mass. Fat transplantation and bioinformatics analysis of TNSST neuronal transcriptomes revealed white adipose as a key modulator of the effects of TNSST neurons on food intake. Together, these studies point to a mechanism whereby TNSST hypothalamic neurons modulate feeding by responding to varying levels of circulating estrogens differentially based on energy stores. This research provides insight into how neural circuits integrate reproductive and metabolic signals, and illustrates how gonadal steroid modulation of neuronal circuits can be context-dependent and gated by metabolic status. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

In this podcast RCLCO interviews CEO of 2HSQ Robert Seldin, who is the US Patent Inventor for the proprietary 2HSQ live/work building conversion and construction method and apartment operating system.

(Featuring Robert Seldin of Madison Highland Live/Work Lofts) https://www.afire.org/podcast/202215seldin/ Mobile information technology has upended US land use regulation, and the ramifications of this technological upheaval are finally coming into view. Everyone in real estate complains about zoning laws. Depending on the municipality, it can determine the success or failure of any project, and quite often, the zoning seems to be completely opposed to the way people want to work, live, and play. How can real estate and zoning be flexible enough to meet the needs of a post-COVID population in cities that were changing long before the pandemic? Rob Seldin, Managing Principal at Madison Highland Live Work Lofts, sat down with AFIRE CEO and podcast host Gunnar Branson on September 7, 2022 to discuss how a flexible approach to office and residential may be a direction for adaptive re-use to solve for an uncertain and fast changing future. Based on the recent article Mr. Seldin wrote for AFIRE Summit Journal, he is unlocking new drivers for asset performance.

Has education in America failed Americans?   An outspoken critic of today's conventional education system and a proud Montessori parent, Luis has the privilege of welcoming educator, teacher, author, and president of The Montessori Foundation, Tim Seldin to the show.    Discussing how and why America's education system has defaulted in the last decade, tune in as Tim shares the benefits of Montessori and how millennials can reclaim education through it.   KEY POINTS: - The problem with education in America today  - What makes the Montessori system different? - Combating the “dumbing down of the American school” - How to get millennials interested in education  - Are charter schools the answer?   QUOTABLES: “I would not be comfortable saying education in America has failed. I think it's much less than what it could be. And I always remember that schools and school systems are built by human beings, and human beings are imperfect.” ​​”I travel around, and I find waiters in restaurants around the world know more than a typical college graduate in America in terms of how their country works and what's really going on politically.” “Intelligence is not rare. It just has many faces. And most kids are much more capable than the school system thinks. But they can't all succeed in the same way at the same pace.”   OTHER RESOURCES: Learn more about Tim Seldin and The Montessori Foundation at: montessori.org   PRODUCTS / RESOURCES:  Love what you're hearing? Follow The Millennial Party on social and share the love! IG | @@themillennialparty_ www.fuckbothsides.com          The Millennial Party is produced by Instapodcasts (visit at www.instapodcasts.com) 

On today's nerdtastically newsworthy episode of #NerdORama, Comic Con Revolution CEO Drew Seldin joins the program to get you up to speed on everything you need to know about the 5th Annual Comic Con Revolution (May 21-22 at the Ontario Convention Center)!!!

AMA Omaha President Elect, Sara Winters, sits down with Cindy McAndrew, Seldin Company VP of Marketing, to discuss Seldin's AMA Omaha In-Home Team of the Year award. A Hurrdat Media Production. Hurrdat Media is a digital media and commercial video production company based in Omaha, NE. Find more podcasts on the Hurrdat Media Network and learn more about our other services today on HurrdatMedia.com.

Shani Mink and SJ Seldin are the co-founders of Jewish Farmer Network -- a grassroots organization of over 2000 farmers, which mobilizes Jewish agricultural wisdom to build a more just and regenerative food system for all. They join Dan Libenson and Lex Rofeberg for a conversation about the Shmita year (year of release), and about how Jews today can combat the pervasive, incorrect idea of "Isn't Jewish farmer an oxymoron?"Jewish Farmer Network's 2022 conference, entitled "Cultivating Culture: A Virtual Gathering of Jewish Famers," will be taking place via Zoom on two consecutive Sundays -- January 30th and February 6th (spaced out in order to reduce Zoom fatigue). Register for the Jewish Farmer Network's conference by clicking here!If you're enjoying Judaism Unbound, please help us keep things going with a one-time or monthly tax-deductible donation. Support Judaism Unbound by clicking here! You can also buy Judaism Unbound merch (hoodies! stickers! mugs! so much more!) by heading to www.judaismunbound.com/store.To access shownotes for this episode, click here.  

Comic Con Revolution, the Inland Empire's family-friendly comic convention, is back December 18 & 19 at the Ontario Convention Center. Kids 12 and under enter for free when accompanied by an adult with a paid ticket.Voice actors from your favorite animated shows & video games such as Batman, Justice League, Gears of War, Miraculous: Tales of Ladybug & Cat Noir, Avatar: The Last Airbender, Genshin Impact, Sailor Moon, The Centurions, and more ready to meet fans, sign autographs and take pictures for an unforgettable experience.And don't forget about the huge AEW wrestling stars Darby Allin, Brian Cage & Sammy Guevara -- they will be in-person meeting attendees all weekend long. Talk about an amazing early holiday gift!

Listen to Dan, Peter, and Jason in our Second Season:  We are discussing the Isaac Asimov novel Foundation And Empire Part II The Mule, Chapter 16-18.  Traders, ....or Traitors .... a Visi-WHAT?  And "Mayor" Indbur hits his limit as things come to a head with a Seldin reveal in the time vault.   www.suchnerds.com 

Causality and causal modeling is one of the hottest topics in machine learning.Jasper LinkedIn: https://www.linkedin.com/in/jasperseldin/The Data Standard LinkedIn: https://www.linkedin.com/company/the-data-standard/

This episode of The D.O. Sportscast, hosted by Thomas Shults, explores the life of Abbe Seldin, who was the first female tennis player at Syracuse University to receive a scholarship in the sport. Tennis beat writer Bryan Brush speaks about Seldin’s experiences facing gender discrimination before arriving at SU, when she fought Title IX alongside Ruth Bader Ginsburg. Our host and editorial director is Thomas Shults. Nick Luttrell is our contributing producer, Luca Serio is our executive producer, Moriah Humiston is our podcast editor, Anish Vasudevan is our assistant digital sports editor and Adam Wolff is our music producer.

The post Susan Wells, Regional Portfolio Manager – Seldin Companies appeared first on KSCJ 1360.

Apologies C&C listeners for the month of silence, but we have not forgotten you! We promise this month will have a lot more planned with interesting upcoming episodes and a new guest host who we could not resist to bring back to the studio (details available on our Patreon page). In the meantime, enjoy this episode with Forbes 30 under 30, Abigail Seldin, as she tells us about what inspired her to leave the city of spires to explore the world of entrepreneurship to create more impact in higher education. Show notes: SHS Foundation: https://www.shs.foundation/ SwiftStudent: https://www.linkedin.com/company/swiftstudent/ Like our show? Consider becoming a Patron for as little as £1! https://www.patreon.com/coffeeandcocktailspodcast

Today's episode is a masterclass on building efficient homes. We're joined by Alex Seldin, a Solar States client who hired us during renovations to his Philadelphia home, and Brian Osborne of Osborne Construction, who was hired by Alex to design the home using Brian's "whole-house organism" approach.  Alex shares his initial vision for the home, including his motivations for going solar, and Brian details on his plans and execution. Brian is what Jared calls "Picasso with a 2x4". He has spent his career thinking deeply about building efficiencies and developing a practical, long-term approach to building green homes. Nobody likes to crack open the walls to their own home for energy improvements. Brian outlines his "200-year solution" for clients so that they don't have to worry about upgrades to indoor air quality, air tightness, or other concerns ever again.  You'll hear the full story from financial and design considerations to execution to life after solar install / renovations.  More about Osborne Construction: http://www.osborne-construction.com/     

Retiring ASCO Chief Medical Officer Dr. Richard L Schilsky gives a far-reaching interview with ASCO in Action podcast host ASCO CEO Dr. Clifford A. Hudis, who examines Dr. Schilsky’s trailblazing medical career, his leadership in ASCO and indelible mark on its research enterprise, and what he sees for the future of oncology. ASCO’s first-ever Chief Medical Officer even offers some friendly advice for Dr Julie Gralow, who starts as ASCO’s next CMO on February 15, 2021. In a touching tribute, Dr. Hudis also shares what Dr. Schilsky’s friendship and mentorship has meant to him personally, and suggests that Rich will still be supporting ASCO on critical priorities moving forward. Don’t miss this exchange with one of oncology’s greats! Transcript DISCLAIMER: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. CLIFFORD HUDIS: Welcome to this ASCO in Action podcast brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insights into the world of cancer care. You can find all of the shows, including this one, at podcast.asco.org. The ASCO in Action podcast is a series where we explore the policy and practice issues that impact oncologists, the entire cancer care delivery team, and the individuals we care for-- people with cancer. My name is Dr. Clifford Hudis. And I'm the CEO of ASCO and the host of the ASCO in Action podcast series. For today's podcast, I am especially pleased to have as my guest my friend, colleague, and mentor Dr. Richard Schilsky, ASCO's chief medical officer. Now, I am sure that many of our listeners have already heard that Dr. Schilsky will be leaving ASCO in February of 2021, retiring. However, I want to reassure everybody that even in retirement, he will continue to make contributions and provide leadership to all of us. And his illustrious and path-blazing career in oncology spanning more than four decades is not quite over thankfully. Rich is ASCO's first chief medical officer. And as such, he has made a truly indelible mark on all of us. He started with a proverbial blank piece of paper. The position had no precedent. It had no budget. It had no staff. But now after just eight years in the role, he has helped make the CMO a critically important position at the society. And I have to say that success is more than anything due to Rich's vision and his leadership. And that's some of what we'll be talking about today. So Rich, thank you very much for joining me today for what I hope is going to be a great casual but informative conversation about your amazing career, your unique role at ASCO, and maybe most importantly in the end what you see for the future of oncology not just in the United States, but around the world. Thanks for coming on, Rich. RICHARD SCHILSKY: Thanks, Cliff. It's great to be here today. CLIFFORD HUDIS: So with that, let's just dive right in and start at the very beginning. Rich, tell everybody why you decided to become an oncologist and maybe share a little bit about what those early days looked like for you and, in that context, what it was like to have cancer at the beginning of your career. RICHARD SCHILSKY: Well, I knew from an early age that I wanted to be a doctor. And in fact, I had written a little essay when I was in sixth grade as a homework assignment called My Ambition. And my mother had tucked that away in a scrapbook. And I found it a number of years ago. And on rereading it, it was quite amazing to me to see what I was thinking about even then. Because I said not only did I want to be a doctor, but I didn't think that was enough, that I wanted to be a medical researcher because I wanted to discover new information that would help people heal from whatever their diseases might be. And so it was never really any doubt in my mind that I would be a physician. I went to medical school at the University of Chicago. But I was living in New York City at the time having grown up in Manhattan. And the only year we had off in medical school, the only time we had off in medical school, was the summer between the end of the first year and the beginning of the second year. So during that time, I went back to Manhattan. And I was able to get a fellowship from the American College of Radiology that allowed me to essentially hang out in the radiation therapy department at New York University Medical Center, which was within walking distance of where I grew up. And so I would go over there every day. And I was taken under the wing of a young radiation oncologist. And of course, I wasn't really qualified to do anything at that point except to follow him around, talk and listen to the patients. But that turned out to be a really formative experience for me because we saw the whole gamut of cancer. We saw head and neck cancers. We saw lung cancer. We saw patients with breast cancer and prostate cancer. And in those years-- this is the early 1970s-- many of these patients have fairly locally far advanced disease and were quite debilitated by it. But listening to their stories, hearing about their hopes and their struggles, really demonstrated to me the human side of cancer. So I went back to school and thought about this in the context of my own personal experience, which dated back to when I was in college when my mother's mother, my maternal grandmother, was diagnosed with breast cancer. This was 1968. And as you well know, there were very few therapies available for breast cancer in the late 1960s, mostly hormone therapies. And my grandmother had the treatment that was considered standard of care at that time, which was extended radical mastectomy followed by chest wall radiation. And some years after that first mastectomy, she had a breast cancer that developed in the opposite breast and had a second extended radical mastectomy and chest wall radiation. And these were very traumatic and disfiguring procedures for her to go through. Anyway, long story short is after another few years, she developed bone metastases and then brain metastases. And there was really very little that could be done for her other than hormone therapies. And having observed her go through that illness and realizing how limited our treatment options were and then having the experience after my first year in medical school pretty well cemented for me that I wanted to be an oncologist. I thought actually about being a radiation oncologist. But then I did my internal medicine rotation in medical school, fell in love with internal medicine. And that sort of put me on the path to be a medical oncologist. The clinical challenge of caring for cancer patients, the emotional attachment to those patients, and, of course, even then, the unfolding biology of cancer was so intellectually captivating that I actually applied for oncology fellowship when I was a senior medical student. So even before going off to do my medical residency, I had already been accepted as a clinical associate at the National Cancer Institute to start two years hence. And that's how I became an oncologist. CLIFFORD HUDIS: So it's so interesting. Because, of course, the story I'm sure for many people interested not just in oncology, but even medical education, there are little things that don't happen nowadays that happened with you like that last little vignette about the early acceptance into an advanced training program before your fellowship among other things. Can you remind us about the timeline? Because I think one of the things that many of our listeners often can lose sight of is just how new oncology really is as a specialty. ASCO itself founded in 1964. And the first medical oncology boards were mid-'70s, right? So you were in med school just before that second landmark, right? RICHARD SCHILSKY: That's right. I graduated from medical school in 1975. I started my oncology fellowship in 1977. And I got board-certified in medical oncology and joined ASCO in 1980. And so that was the time frame at that point. CLIFFORD HUDIS: So the internal medicine was actually, if I heard you right, just two years, not the now traditional four. RICHARD SCHILSKY: Yeah. I was a short tracker. I did only two years of internal medicine training rather than three. I did my training at Parkland Hospital and University of Texas Southwestern in Dallas with at that time a legendary chair of medicine, Don Seldin, who I had to get permission from him to leave the program prior to completing the third year of residency because I had already been accepted into fellowship at NCI. And he, Seldin, who was a brilliant chairman and a brilliant nephrologist, was not at all interested in cancer. And it took a bit of-- I was going to say arm twisting, but it really took bleeding on my part to get him to agree to allow me to leave the residency program to go to the NCI. But he eventually agreed. And in those years, the first-year clinical fellowship at the NCI was like being an intern all over again. There were about 15 of us. We were on call overnight in the clinical center once every two weeks. We cared for all of our inpatients as well as had a cadre of outpatients. We did all of our own procedures. We had no intensive care unit. So patients who were sick enough to require ventilator support, we cared on the floor in the inpatient service on our own with guidance from senior oncologists. It was a bit different from the way it is now. But, of course, it was fantastic on-the-job training because we just learned a ton and had to learn it very quickly. CLIFFORD HUDIS: So that's actually a great segue to the advances because there was a lot to learn then. But, wow, there's a lot more to learn, I think, now. And I have real sympathy for trainees and younger oncologists for the breadth of what they need to learn. Again, just testing your memory, but platinum came along pretty much in the mid-'70s as well, right? That was a pivotal expansion of the armamentarium for us. So what do you see-- when you summarize progress in cancer research and care over these decades, what do you think are the most pivotal or revolutionary milestones that you identify over the span of your career? RICHARD SCHILSKY: Yeah. It's really interesting to think about it historically. There were the early years of discovery in oncology from the 1950s to the 1970s when we really had the introduction of the first chemotherapy drugs and the miraculous observation that people with advanced cancer could actually obtain a remission and, in some cases, a complete remission with chemotherapy and combination chemotherapy in particular. And so that was the formative years of oncology as a medical specialty and really proof of concept that cancer could be controlled with drugs. When we got into the 1980s, the 1980s in many respects were the doldrums of progress in clinical oncology. There really was not a lot of innovation in the clinic. But what was happening and what was invisible to many of us, of course, was that was the decade of discovery of the fundamental biology of cancer. That's when oncogenes were discovered, when tumor suppressor genes were discovered, when it became clear that cancer was really a genetic disease. And that is what transformed the field and put us on the path to targeted therapy and precision medicine as we think of it today. So I think that clearly understanding the biology of cancer as we do now and all that it took to lead us to that point, which was a combination of understanding biology, developing appropriate technology that would, for example, enable the sequencing of the human genome and then the cancer genome. And the other formative technology in my opinion that really changed the way we care for cancer patients was the introduction of CT scanning. When I was still a fellow at the NCI, we did not have a CT scanner. If we needed to get detailed imaging of a patient, we did tomography. And if you remember what tomograms looked like, they were really blurry images that you could get some depth perception about what was going on in the patient's chest or abdomen. But they really weren't very precise. When CT scanning came along, it really revolutionized our ability to evaluate patients, assess the extent of disease, stage them in a much more precise way, which then allowed for better patient selection for curative surgery, better radiation therapy planning. So we don't often point to imaging advances as some of the transformative things that paved the way in oncology, but I think imaging is really overlooked to some extent. So I think the technology advances, the biological advances, are the things that really allowed the field to move forward very quickly. And by the time we got into the mid-1990s, we were beginning to see the introduction of the targeted therapies that have now become commonplace today. And then it was around 2000, I think, that we saw the introduction of Gleevec. And I'm reminded always about an editorial written by Dan Longo in The New England Journal a few years ago. And Dan and I were fellows together. We worked side by side on the wards at the clinical center and became very good friends. And Dan in his role as a deputy editor of The New England Journal wrote an editorial a few years ago that was titled "Gleevec Changed Everything." And Gleevec did change everything. It changed our entire perception of what were the drivers of cancer and how we might be able to control cancer very effectively and potentially put it into long-term remission. Now, of course, we know now that the whole Gleevec story is more of an exception than a rule in targeted therapy. And, of course, we know that tumors become resistant to targeted therapies. But we couldn't have known any of this back in the early years of oncology because we had no real insight into what caused cancer to grow or progress. And the notion of drug resistance, while we realized that it occurred, we had no idea what the mechanisms were. So it's such a different landscape now than what it used to be. It's quite remarkable. CLIFFORD HUDIS: So as you tell the story, there's, of course, a lot of focus on technology, whether it's biology and understanding the key features of malignancy or imaging or more. But what I also note in your story and I want to come back to is the people. And I can't help but reflect on where we are in this moment of the COVID-19 pandemic. Yes, we've moved to telemedicine. Everything can be accomplished via technology. And, yet, the human touch is so important. When we think about being in the room with people, when we think about face to face from the context of career development and your own career, you touched on Dr. Seldin, I think, already from the perspective of internal medicine training. But are there are other mentors or important shapers of your career that you think we should know about? RICHARD SCHILSKY: Well, probably, the most influential person early in my career in medical school was John Altman. John, you may know, was the inaugural director of the University of Chicago's NCI-designated Cancer Center, which was one of the very first NCI-designated cancer centers in 1973 after the National Cancer Act of 1971 created the cancer centers program. And John, who was a leading oncologist studying Hodgkin and non-Hodgkin's lymphoma, was a faculty member there. He was the director of our cancer center as I said. He took me under his wing even when I was in medical school and served as a real role model and mentor to me. When I was in my internal medicine training as I mentioned earlier, Don Seldin, the chair of medicine, was never particularly interested in oncology. So, to some extent, I didn't have-- I had great internal medicine training. But I did not have good mentorship in oncology. When I got to the NCI, then my whole world really opened up. And the two pivotal people there in my career were Bob Young, who was chief of the medicine branch and was my clinical mentor and remains a mentor and friend to this day, and then, of course, Bruce Chabner, who was the chief of the clinical pharmacology branch. And in my second year of fellowship when we all went into the laboratory, I went into Bruce's lab. And that's where I really got interested in the mechanism of action of anti-cancer drugs and ultimately in drug development and early phase clinical trials. And both Bob and Bruce remain very close to me even today. CLIFFORD HUDIS: So I'm concerned about time on our call today on our discussion. Because we could obviously fill lots of hours on all of these remarkable experiences and amazing people you worked with. But I'm going to ask that we fast forward a little bit. You and I share, I think, passion and love for ASCO. So I think that it's reasonable for us to focus a little bit on that for the time we have left here. You didn't start out obviously as chief medical officer at ASCO. But you were a really active ASCO volunteer and leader. Maybe tell us a little bit about some of the ASCO volunteer roles that you engaged in and what that meant to you at the time and how that led to this role. RICHARD SCHILSKY: Well, I'll be brief. I joined ASCO in 1980 at the first moment that I was eligible to join ASCO. I had attended my first ASCO meeting the year before, 1979, when I was still in my fellowship training. And it was clear to me even then when the whole annual meeting was about 2,500 people in two ballrooms in a hotel in New Orleans that that was a community of scholars and physicians that I wanted to be a part of. And so, over the years, I did what people do even today. I volunteered to participate in whatever ASCO activity I could get involved with. Over the years-- I think I counted it up not too long ago-- I think I served or chaired 10 different ASCO committees, more often serving as a member, but in a number of those committees also serving as the chair over many years. And as I became more deeply involved in ASCO and saw other opportunities to engage, I had the opportunity to run for election to the board and was-- after a couple of tries was elected to serve on the board and then eventually elected to serve as ASCO president in 2008-2009. But the attraction of ASCO in many ways was a community of diverse but, in many ways, like-minded people, people who had similar passion and drive and focus. But I think what you get at ASCO in many ways is the wonderful diversity of our field. If you work in a single institution for much of your career as I did and as you did, you get to know that institution pretty well. You get to know its perspectives and its biases and its strengths and its weaknesses. But there's a whole world of oncology out there. And you can get exposed to that at ASCO because you meet and work with colleagues from every clinical setting, every research setting, people who have remarkable skills and interests and passions. And it's just a wonderful environment to help develop your career. So I consider myself to be extremely fortunate to have had the journey in ASCO that I've had culminating, of course, with ultimately my coming on the staff as ASCO's first chief medical officer. CLIFFORD HUDIS: We often joke about that blank sheet of paper. But in retrospect, it's very obvious that you had built up that collection of LEGO blocks, and then you assembled them all into the ASCO Research Enterprise, a name you gave it. And it really, in retrospect, builds, I think, very cleanly upon all of your prior experience, but also the vision that you developed based on that experience for how research should be conducted. Can you maybe share with everybody the scope and vision for the ASCO Research Enterprise, what the intent was, and where you see it going, and what it includes today? RICHARD SCHILSKY: Sure. I won't claim that I came to ASCO with the whole thing fully developed in my mind. As you said, when I came, I literally did have a blank slate. Allen Lichter, who hired me, said, come on board and help me make ASCO better. And so I, in a sense, reverted to what I knew best how to do, which was clinical research. And having in my career been a cancer center director, a hem-onc division chief, a cooperative group chair, I had a lot of experience to draw on. And it was obvious to me that ASCO was fundamentally an organization that took in information from various sources, evaluated it, vetted it, collated it, and then disseminated it through our various channels, most notably our meetings and our journals. But ASCO itself did not contribute to the research enterprise. And that seemed to me to be a lost opportunity. We knew that ASCO had lots of data assets that could be of interest to our members and to the broader cancer community. But they were scattered all around the organization and not particularly well annotated or organized. So we began to collate those. And they are now available to ASCO members on the ASCO data library. I recognized that we did not have an organized unit in ASCO to support or facilitate or conduct research. So, in 2017, we formed the Center for Research and Analytics and brought together staff who were already working at ASCO but scattered in different departments but all people who had an interest in clinical research or research policy and brought them into this new unit, which has really become the focal point for research work at ASCO. We recognized that ASCO members for many years were interested in surveying their colleagues, surveying other ASCO members, to help advance research questions. But ASCO actually had a policy that prohibited that. So that never really made good sense to me. It seemed like a lost opportunity. And we were able to create a program and have the ASCO board approve it whereby any ASCO member could opt in to participate in what we now call the Research Survey Pool. And in doing so, they are essentially agreeing to participate in research surveys conducted by their colleagues. So that program is now up and running. There are, I think, eight surveys that have been completed or are currently in the field. And this is now a service that ASCO provides through CENTRA to its members to enable them to survey their colleagues for research purposes. Most importantly, I think we saw an opportunity back in 2014 or 2015 to begin to learn from what our colleagues were doing in clinical practice as they began to deploy precision medicine. And there was a lot of genomic profiling that was going on at that time. It was revealing actionable alterations in roughly 30% or so of the tumors that were profiled. But there was a lot of difficulty in doctors and patients obtaining the drugs that were thought to be appropriate to treat the cancer at that particular time because most of those drugs would have to be prescribed off label. And there was not a sufficient evidence base to get them reimbursed. And, moreover, even if they could be reimbursed, there was no organized way to collect the patient outcomes and learn from their experiences. So that led to us developing ASCO's first prospective clinical trial, TAPUR, which really solves both of those problems. Through the participation of the eight pharmaceutical companies that are engaged with us in the study, we are providing-- at one point, it was up to 19 different treatments free of charge to patients. These are all marketed drugs but used outside of their FDA-approved indications. And we were collecting data on the patients, the genomic profile of cancer, the treatment they received, and their outcomes in a highly organized way. And so now this is a study that we launched in 2016. We're now almost to 2021. We have more than 3,000 patients who have been registered on the study, meaning consented to participate, more than 2,000 who have been treated on the study. And we are churning out results as quickly as we can about which drugs are used or not useful in the off-label setting for patients whose tumors have a specific genomic profile. So we built all this infrastructure. And having this in place has also then allowed us to respond rapidly to unmet needs. So when the COVID-19 pandemic overwhelmed all of us, and when our members were looking for information about what was the impact of COVID-19 on their patients, one of the things we were able to do because we had CENTRA, because we had a skilled staff and an infrastructure, was to very quickly stand up the ASCO COVID-19 registry, which we launched in April of this year. And there are now about 1,000 patients who've enrolled in the registry from around 60 practices that are participating. And we will follow these patients now longitudinally and learn from their experiences what has been the impact of the COVID-19 illness on them and their outcomes, how has it disrupted their cancer care, and ultimately how that impacts their overall cancer treatment outcomes. So as I now contemplate leaving ASCO after eight years having started with a blank slate, I'm very proud of the fact that I think I'm leaving us with a remarkable infrastructure. We now have a clinical trials network of 124 sites around the country participating in TAPUR that we never had before. We have through the work of CancerLinQ a real-world evidence data generator that is beginning to churn out valuable insights. We have a capacity to survey ASCO members for research purposes. We have an ability to stand up prospective observational registries to gather information longitudinally about patients and their outcomes. We have a core facility in CENTRA with highly skilled data analysts and statisticians that can support these various research activities. So ASCO is now primed, I think, to really contribute in a very meaningful way to the gaps in knowledge that will forever exist in oncology just because of the complexity of all the diseases we call cancer. And that's what I mean by the ASCO Research Enterprise. It is in fact remarkable and, I think, powerful enterprise if we continue to use it effectively. CLIFFORD HUDIS: Well, that's an interesting segue to my next thought, which is really about what comes next. I'll talk about you. But let's start with ASCO first. Your successor, Dr. Julie Gralow, obviously has been announced publicly. She's an accomplished clinician and researcher. She has a known recognized passion for patients, patient advocacy, clinical research through her leadership at SWOG but also health care equity and global oncology. So from your perspective, having created all of these assets and resources, what advice would you give Dr. Gralow publicly on how to make the position hers, what to take us to next? And I do want to acknowledge for everybody listening that the hints I've been making up until now are that Rich has agreed that he will continue to contribute as a leader to TAPUR for the short term, at least, at least the next year helping Julie get fully oriented to this program and others. So what will your advice be to Julie? RICHARD SCHILSKY: That's a great question. She's a great selection. And congratulations on hiring her. I think there are two key issues, I think, maybe three. One is to have a broad scope and cast a wide net. Oncology care and cancer research and cancer biology are incredibly complicated and nuanced and broad in scope. And although Julie is an accomplished breast cancer clinician and researcher, in this role at ASCO, you have to be very broad. You have to understand all of cancer care, all of cancer research, all of policy and advocacy not as an expert in necessarily in any one aspect of ASCO's work, but you have to understand the impact of all of those things on cancer care providers and on cancer patients. And it's important to always be looking to the future. The future is going to be here before you know it. And we as a professional society have to prepare our members for that future. So that leads me to the second point, which is listen to the members. The members are the people on the front lines who are delivering care to patients every day. And, fundamentally, ASCO's job is to be sure that our members have all the tools and knowledge and resources that they need to deliver the highest quality care to patients every day. So listening to what they need, what their struggles are, what their burdens are, is extremely important. And then the third thing I would recommend to her is that she get to know the staff and colleagues that she'll be working with. ASCO has a remarkably accomplished, skilled, motivated, passionate staff, many of whom have been with the organization for years, if not decades, who understand what ASCO can and cannot do and who understand what our members need. And she will be well advised to spend a good portion of her first few months on the job just listening and learning from her colleagues. CLIFFORD HUDIS: That's always good advice for anybody making a big career move. But, of course, the wisdom you bring to it is palpable and much appreciated. And I'm sure Julie will be taking your advice. And, by the way, so will I continue to do that even after you make your move. So speaking of your retirement, can you share with us a little bit about what it's actually going to look like for you? Is it about family? Or are you still going to have some professional engagement? Again, I suggest that there might be some already, but maybe you could expand on it. RICHARD SCHILSKY: Yeah. I'm still fully focused on my work at ASCO. And, of course, as you know, when I wake up on February 15, I will no longer be ASCO's chief medical officer. And it's going to be a bit of a rude awakening. Fortunately, I will be able to continue my engagement with ASCO through the TAPUR study as you mentioned. I will, of course, forever be at ASCO member and a donor to Conquer Cancer and be willing to serve the society in any way. I have a number of activities that I've been involved with even throughout my time at ASCO. Not-for-profit boards, for example-- I'm on the board of directors of Friends of Cancer Research. I'm on the board of directors for the Reagan-Udall Foundation for FDA. I plan to continue with those activities as long as they'll have me. I've been serving the last few years on the board also of the EORTC, the large European cooperative clinical research group. And I expect to continue in that role. Beyond that, I will see what opportunities come my way. I think one of the things about retirement if you will that I'm looking forward to is the opportunity to pick and choose what to work on based on what interests me without having the burdens of having a full-time job. On the personal front, of course, we're all looking forward to crawling out from the pandemic. I've basically been locked in my home outside Chicago since March. And I'm looking forward to getting back out to a little bit of a social life. As you know, I have two grown daughters and now three grandchildren, two of whom are in Atlanta, one of whom is near by us in the Chicago area. So looking forward to spending time with them as well. So it will be a change for me to be sure after working as hard as-- I feel like I've worked for really now 45 years since I graduated from medical school. But I also feel like I'm not quite done yet and that I still have ways in which I can contribute. I just feel like at this point, maybe it's time for me to choose how I want to make those contributions and spend a little bit more time doing some other things. CLIFFORD HUDIS: Well, both you and my predecessor, Allen Lichter, are modeling something, have modeled something, that I think is not often discussed but can be very important. For people and for institutions, change is not a bad thing. And setting the expectation that you will pour your heart and soul into something but not necessarily do it alone or forever and not prevent others from taking that role at some point, that's a really-- I think it's a selfless kind of sacrifice in a way. Because, of course, you could stay and do what you're doing for longer. But as you and I have discussed, there is a value for all of us collectively in having fresh eyes and new people take organizations in a new direction. That's how I ended up here frankly. And I think that's the kind of opportunity you're creating right now, something that should be celebrated in my opinion. RICHARD SCHILSKY: Well, thanks. And I couldn't agree more. When I look back at the arc of my career and having all the different kinds of leadership roles that I've had, I basically have made a job change every 8 to 10 years. I was the director of our cancer center for nearly 10 years. I was associate dean for clinical research at the University of Chicago for eight years, another position that I created from a blank slate at that institution. The exception was serving 15 years as a CALGB group chair. But that was a position I really loved and enjoyed and felt like at the end of the first 10 I hadn't quite accomplished everything I wanted to accomplish. But the point is that I think it is both necessary for organizations to have regular leadership change. And it's also refreshing for us as individuals. There gets to a point where you feel like you can do your job in your sleep. And I actually think that's a good time to make a change. Because if that's the way you feel, you're not being sufficiently challenged. And you're probably not being sufficiently creative. And so it's a good time to move on and refresh your own activities and give your organization a chance to bring in someone to hopefully build on whatever you've created and bring it to the next level. CLIFFORD HUDIS: Well, I agree with all that, although I think your comment there about doing the job in your sleep would not apply because I'm pretty confident that the environment and opportunities have continued to evolve in a way that has made it interesting from beginning to end. But you don't have to rebut me on that. I just want to thank you very, very much, Rich. As we set up this podcast, I expected that we would have a really fun and enlightening conversation. And, of course, you did not disappoint. We could talk for much, much longer if we only had the time. On a personal note to you and for the benefit of our listeners, I want to share that Rich has been for me a remarkable friend and mentor and colleague. I first met Rich at the very beginning of my career when my mentor, Larry Norton, pushed me out from Memorial into the larger world. And he did that first and primarily through ASCO and the Cancer and Leukemia Group. Those are really the two places where I was exposed to the world. And through the CALGB, Rich really began to offer me and others, many others, opportunities that shaped careers plural, mine and others. So when I got to ASCO as CEO, Rich was there. And I knew I could always depend on you to be clearheaded, intellectually precise, constructive, visionary. And the thing about you, Rich, is that you never would say yes to anything unless you knew for sure you could do it and indeed, I think, how you could do it. I always share this story which your staff at CENTRA pointed out to me. And I have to admit that I hadn't picked it up myself. But in all the years of now working down the hall from Rich, probably hundreds and hundreds of hours of meetings, he never has taken a note in front of me. And, yet, everything we talk about, every action item we conclude to pursue, they all get done. So I don't know, Rich. You have a remarkable way of organizing your thoughts and your plans, keeping it together, and getting things done. And I'm going to miss that tremendously in the years ahead. So, Rich, I want to say congratulations. Congratulations on reaching this really important milestone in your life. Thank you on behalf of ASCO and the broader oncology community and the patients we care for and their families for making the world a better place. And just as a small thing, thank you for joining me today for this ASCO in Action podcast. RICHARD SCHILSKY: Thank you, Cliff. It's been great. CLIFFORD HUDIS: And, for all of you, if you enjoyed what you heard today, don't forget to give us a rating or a review on Apple Podcasts or wherever you listen. And, while you're there, be sure to subscribe so you never miss an episode. The ASCO in Action podcast is just one of ASCO's many podcasts. You can find all of the shows at podcast.asco.org. Until next time, thank you for listening to this ASCO in Action podcast.

Drew Seldin explains how he and his partners started Comic Con Revolution Ontario. Get 10% Off at Betterhelp.com/DreamerComics with Discount Code "Dreamer"

Cletus Seldin was born in East Yaphank, New York he was a star athlete At Longwood High School in Middle Island, New York, Seldin playing cornerback and wide receiver on the Longwood Lions football team, which won the 2004 Long Island championship, and wrestled and learned jiu jitsu. In his senior year he set the New York State deadlifting record for men weighing up to 145 pounds (66 kg), by lifting 470 pounds. This past week he broke his own record by winning 25 of 26 fights, with 21 knockouts, when he fought Luis Florez, Mark and AJ welcome back the the reigning Super Lightweight Champion of the North American Boxing Association; The Hebrew Hammer Cletus Seldin to talk about his latest win. Tune in each week on 540 am in NY NJ CT and streaming on www.sportstalknylive.com at 7pm Sundays for the live broadcast.Please take a moment to like our fan page WLIE 540 AM SPORTSTALKNY and follow us on twitter @sportstalkny

This week Christina and Damien sit down with Cletus Seldin to discuss his collecting journey. How did he get started and how did a pro boxer become an avid collector. What was It like to be on stage for Fundays 2018 and his role In the Funko documentary Making Fun?

Drew Seldin explains how he and his partners started Comic Con Revolution Ontario. Best Quality Clothing from our Sponsor Mack Weldon For 20% off your first order, visit mackweldon.com AND ENTER PROMO CODE: DREAMER Thanks to our sponsor Skillshare. Learn how to make comics like the pros with Skillshare. Get 2 Months Free when you sign up at www.skillshare.com/dreamer Visit www.ComicConRevolution.com/Ontario/ for tickets May 16th and 17th

Did you know that one of the best low and moderate income housing programs is helping longtime homeowners stay in their homes? That's what Rebuilding Together Philadelphia is doing and we'll tell you how you can help. I speak with Stefanie F. Seldin, Rebuilding Together Philadelphia President and CEO.https://www.rebuildingphilly.org/I can't wait for you to meet Aliyah Khaylyn. She's a two time winner of The Marian Anderson Award Young Artist Study-Grant. She'll be going to Berklee School of Music to pursue a career in performance and the music industry. Aliyah is not only an incredible talent you will be moved by her maturity and values. We'll also get to hear her sing – https://www.facebook.com/aliyahkhaylyn/But first – we talk with Susan Tatsui-D'Arcy author of Beat the College Admissions Game with ProjectMerit who has a winning strategy for helping students get into the college of their dreams. http://www.meritworld.com/wp/

Did you know that one of the best low and moderate income housing programs is helping longtime homeowners stay in their homes? That's what Rebuilding Together Philadelphia is doing and we'll tell you how you can help. I speak with Stefanie F. Seldin, Rebuilding Together Philadelphia President and CEO.https://www.rebuildingphilly.org/

Stefanie Seldin, Executive Director of Rebuilding Together Philadelphia, shares her favorite songs on this August 9, 2019 episode of Life Grooves. The show originally aired on GTown Radio, Philadelphia.

Cette semaine au balado boxe « Le compte de 8 », Francis Paquin et Adrien Meure reviennent sur la victoire de Gennady Golovkin et discutent de la revanche entre Simon Kean et Dillon Carman.

1. Dazn Card: Gennady Golovkin Stops Steve RollsOscar De La Hoya Not Impressed Tips into GGGAli Akhmedov Stops Marcus McDanielIsrael Madrimov stops Noberto GonzalezCharles Conwell Beats Courtney PenningtonBrian Ceballo Beats EyubovNikita Ababiy wins2. Oscar Valdez Dominates Jason Sanchez Gabriel Flores winsMichael Seals Knocked Out Christopher BookerFriday Night- Cletus Seldin Stops Zab Judah.James Mcgirt gets a Draw. Roberto Duran Jr. gets SD3. Eddie Hearn says he has Proposal from WBC to make Whyte vs Rivas for Interim Championship4. Tyson Fury says Many Believe he is the best of his ERA????Notes:David Allen believes he will beat David Price in devastating fashion Shakur Stevenson to Headline July 13 in Newark according to Top Rank Vice President Carl MorettiUsyk wants to Participate in a WBSS Heavyweight Tourney Manny Pacquiao angered by Keith Thurman Comments looks to show him lessonOne Free Month of Dazn On TBV http://bit.ly/ThaBoxingVoicexDAZNhttps://www.patreon.com/ThaboxingvoiceBUY THA BOXING VOICE T-SHIRT HERE http://thaboxingvoice.com/storePLEASE SUPPORT!!! SUBSCRIBE, SHARE & LIKEPlease check out our facebook page and hit the like button. https://www.facebook.com/Thaboxingvoiceradio GOOGLE PLUS https://plus.google.com/107960664507143008932/posts?tab=XXiWeb Sitehttp://thaboxingvoice.com/Radio show: http://www.blogtalkradio.com/thaboxingvoiceradioTwitter: @Thaboxingvoicehttps://twitter.com/thaboxingvoiceAudio only Podcast subscribe herehttps://itun.es/us/oY7JJ.c#GGG #Canelo #TysonFury

This time, we are previewing Comic Con Revolution – Ontario (http://www.comicconrevolution.com/ontario/), with two of the creative forces behind it, from Atomic Crush Events, Mike Scigliano and Drew Seldin. It’s a big third year, on-deck, for the crew at CCR. Listen in and find out more!

One of the best ways to address affordable housing is to make sure low income longtime home owners can stay in their homes. Loraine Ballard Morrill speaks with Stefanie Seldin of Rebuilding Together Philadelphia which revitalizes communities by transforming vulnerable houses into safe, healthy and energy-efficient homes. RTP brings volunteers and communities together to repair homes and improve lives. Stefanie also talks about their annual fundraiser Run to Rebuild on Saturday May 18th. https://www.rebuildingphilly.org/

Today's guests are Stefanie F. Seldin and Tony Gonzalez of Rebuilding Together Philadelphia (RTP). Stefanie is president and CEO and Tony is program manager.Rebuilding Together Philadelphia (RTP) revitalizes communities by transforming vulnerable houses into safe, healthy and energy-efficient homes. RTP brings volunteers and communities together to repair homes and improve lives. Each year, RTP and more than 1,300 volunteers provide free safe and healthy home repairs for 75 to 100 homeowners.In this interview, Stefanie and Tony talk about RTP's several of its programs include Block Builds, Vo-Tech in the House and a $400,000 grant from the Pennsylvania Housing Finance Agency to pay for home repairs for senior residents in Philadelphia.Stefanie joined RTP as Executive Director in November 2013. Before coming to RTP, Stefanie was the managing attorney for Philadelphia VIP, an agency that recruits volunteer attorneys to assist low-income residents facing civil legal problems threatening their basic human needs. Shelter is first on that list of needs, and housing issues have been Stefanie’s focus for the past 10 years. Stefanie aims to put the housing difficulties faced by low-income families in the hearts and minds of thousands of volunteers. Stefanie has a BA from the University of Pennsylvania and a JD from Georgetown University Law School. Tony joined RTP in February 2018. With a background in healthcare administration and construction management, Tony brings a variety of experiences to the RTP staff. Prior to joining RTP, Tony worked as a Community Programs Coordinator for Esperanza Health Center where he administered lay health education and a youth fitness programs for the surrounding community.For more information:Rebuilding Together PhiladelphiaJumpstart Germantown See acast.com/privacy for privacy and opt-out information.

Happy Friday folks! This week on the show I’ve got Marisol Gomez-Mouakad, writer/director/producer of Angelica. The film deals with colorism and other issues in the Caribbean. I also have Stephanie Seldin Howard, director/producer of the documentary The Weight of Honor. It’s a film that looks at the courageous caretakers of veterans who have been catastrophically wounded in America’s longest war. I’m also going to the red carpet of the DC Black Film Festival to share some of the thoughts from filmmakers you’ve heard on the show as well as comic artist Sanford Greene and the hilarious, legendary Sinbad!  Plus, your Picture Lock Question of The Week from a couple weeks ago is read on the show. Follow Marisol here: https://www.facebook.com/gomezmouakad/ Find out more about The Weight of Honor here: https://theweightofhonormovie.com/ See the DCBFF interviews here: https://www.youtube.com/watch?v=bjNr0Ej5B3U&list=PLVaehsAgM7Iru9fNREal_n3Qy0fb0_pG1 Picture Lock Links: Take my PR For The Indie Filmmaker online course here: https://indiefilmpr.thinkific.com/ Get a partner as passionate as you in your film or film event's publicity: www.picturelockpr.com Subscribe to this podcast in iTunes: https://itunes.apple.com/us/podcast/kevin-sampsons-picture-lock/id639359584?mt=2 Be sure to visit www.picturelockshow.com for everything Picture Lock! Please give us a review on whatever platform you listen to this podcast on. Thanks so much for your continued support. Drop a line a picturelockshow@gmail.com to say hi and let us know what you think of the show. FACEBOOK: www.facebook.com/picturelockshow SNAPCHAT: https://www.snapchat.com/add/picturelockshow YouTube CHANNEL:http://www.youtube.com/picturelockshowTWITTER:https://twitter.com/picturelockshowINSTAGRAM:http://instagram.com/picturelockshowPINTEREST:http://pinterest.com/picturelockshow

This time, we are previewing Comic Con Revolution – Ontario (http://www.comicconrevolution.com/ontario/), with two of the creative forces behind it, from Atomic Crush Events, Mike Scigliano and Drew Seldin. It’s a big sophomore year, on-deck, for the crew at CCR. Listen in and find out more!

Francis Paquin, Adrien Meure et Jean-Luc Legendre reviennent sur la défaite subie par David Lemieux contre le champion des poids moyens de la WBO Billy Joe Saunders.

"The Hebrew Hammer", Cletus Seldin calls in to TALKBOX to chat with Woodsy after suffering his first loss to Yves Ulysse Jr in Canada on Saturday night. Seldin discusses the fight, evaluates & praises Ulysse performance, and talks bouncing back stronger for a possible fight in January.  Then, Woodsy calls up fighter Mike "Yes Indeed" Reed, who suffered his first loss back in November to Jose Ramirez. Reed chats with Woodsy about his Never-Give-Up Mentality. He explains what he learned technically and mentally from the loss to Ramirez and what fans can expect next from him.     

Tonight we come back at ya live at 10pm CST in our normal time slot. 1-347-857-1060 is the number to hit us up via phone. We breakdown the Billy Joe Saunders vs David Lemieux fight from last night. Is Saunders the real deal? What trouble could he cause for Golovkin or Canelo? What does Lemieux do from here also? Oh, and we had another "Left Hand problem" it seems. Big time Washington D.C. Prospect Antoine Douglas was battered by Gary O'Sullivan in the semi main event. Does Douglas move on from this and still become a player in the middleweight division in the next couple years, or does he really have some work to do? Should O'Sullivan get another crack at the WBO strap? Was Yves Uylsse Jr. win over Cletus Seldin the most one sided win of the year? Even being a "Real American" couldn't the less experienced Seldin. He's a fun fighter, but this may be the last we see of the "Hebrew Hammer" in the boxing world. We also breakdown our Top 5 Divisions in boxing in a Pound for Pound manner as well. A light show, but always a fun time, so beat the count, and start your fight of the week out with the guys this Sunday night! Make sure to subscribe, share, rate and comment as we are now on iTunes and Stitcher radio. We thank you for the support!

Tonight we come back at ya live at 10pm CST in our normal time slot. 1-347-857-1060 is the number to hit us up via phone. We breakdown the Billy Joe Saunders vs David Lemieux fight from last night. Is Saunders the real deal? What trouble could he cause for Golovkin or Canelo? What does Lemieux do from here also? Oh, and we had another "Left Hand problem" it seems. Big time Washington D.C. Prospect Antoine Douglas was battered by Gary O'Sullivan in the semi main event. Does Douglas move on from this and still become a player in the middleweight division in the next couple years, or does he really have some work to do? Should O'Sullivan get another crack at the WBO strap? Was Yves Uylsse Jr. win over Cletus Seldin the most one sided win of the year? Even being a "Real American" couldn't the less experienced Seldin. He's a fun fighter, but this may be the last we see of the "Hebrew Hammer" in the boxing world. We also breakdown our Top 5 Divisions in boxing in a Pound for Pound manner as well. A light show, but always a fun time, so beat the count, and start your fight of the week out with the guys this Sunday night! Make sure to subscribe, share, rate and comment as we are now on iTunes and Stitcher radio. We thank you for the support! This podcast is sponsored by Anchor

Tonight we come back at ya live at 10pm CST in our normal time slot. 1-347-857-1060 is the number to hit us up via phone. We breakdown the Billy Joe Saunders vs David Lemieux fight from last night. Is Saunders the real deal? What trouble could he cause for Golovkin or Canelo? What does Lemieux do from here also? Oh, and we had another "Left Hand problem" it seems. Big time Washington D.C. Prospect Antoine Douglas was battered by Gary O'Sullivan in the semi main event. Does Douglas move on from this and still become a player in the middleweight division in the next couple years, or does he really have some work to do? Should O'Sullivan get another crack at the WBO strap? Was Yves Uylsse Jr. win over Cletus Seldin the most one sided win of the year? Even being a "Real American" couldn't the less experienced Seldin. He's a fun fighter, but this may be the last we see of the "Hebrew Hammer" in the boxing world. We also breakdown our Top 5 Divisions in boxing in a Pound for Pound manner as well. A light show, but always a fun time, so beat the count, and start your fight of the week out with the guys this Sunday night! Make sure to subscribe, share, rate and comment as we are now on iTunes and Stitcher radio. We thank you for the support! This podcast is sponsored by Anchor

Tonight we come back at ya live at 10pm CST in our normal time slot. 1-347-857-1060 is the number to hit us up via phone. We breakdown the Billy Joe Saunders vs David Lemieux fight from last night. Is Saunders the real deal? What trouble could he cause for Golovkin or Canelo? What does Lemieux do from here also? Oh, and we had another "Left Hand problem" it seems. Big time Washington D.C. Prospect Antoine Douglas was battered by Gary O'Sullivan in the semi main event. Does Douglas move on from this and still become a player in the middleweight division in the next couple years, or does he really have some work to do? Should O'Sullivan get another crack at the WBO strap? Was Yves Uylsse Jr. win over Cletus Seldin the most one sided win of the year? Even being a "Real American" couldn't the less experienced Seldin. He's a fun fighter, but this may be the last we see of the "Hebrew Hammer" in the boxing world. We also breakdown our Top 5 Divisions in boxing in a Pound for Pound manner as well. A light show, but always a fun time, so beat the count, and start your fight of the week out with the guys this Sunday night! Make sure to subscribe, share, rate and comment as we are now on iTunes and Stitcher radio. We thank you for the support! This podcast is sponsored by Anchor

Fresh off his HBO Boxing TKO debut at Nassau Coliseum

HBO Boxing Insiders Eric Raskin and Kieran Mulvaney break down Daniel Jacobs' dominant 12-round decision win over Luis Arias, as well as TKO victories on the undercard for Jarrell "Big Baby" Miller and Cletus "The Hebrew Hammer" Seldin.

See him headline Star Boxing 28 This Thursday night at The Paramount

Jay Seldin (@phototraveler8) is a fine art photographer, photo travel entrepreneur, and instructor. Jay has spent the bulk of his career as a teacher, whether teaching graphic design and photography at the high school level, or more recently conducting workshops and photo tours all over the world. This conversation tracks Jay's early career and how he got into teaching, his accidental discovery of the Macintosh, how he transitioned into leading workshops and tours, and how Prescott learned the graphic design trade in 1998–99 as a high school senior. Environmental Portraits in Cuba, by Jay Seldin Show Notes & Links Jay defines himself as a teacher, a photographer, and world traveler. He is a curious person and a teller of tales. His style can be defined as an “environmental portrait photographer” Jay Seldin on YouTube Jay's photo career began when he was required to take a humanities class in college. That class was an introduction to Black and White Photography. Developing a print in a darkroom was Jay's “lightbulb moment” (and that lightbulb was probably amber) When he was 18, Jay did his first cross-country road trip to San Francisco On The Road by Jack Kerouac on Amazon and on Audible Jay earned 60¢/hr at his first photo job, working in a photo studio in New York Photography was considered “Industrial Arts” and “Art” depending on the school, and the state Jay taught at West Orange High School, Dwight Morrow High School, and later Columbia High School Ansel Adams, famous landscape photographer Mary Ellen Mark Eugene Richards Lucien Clergue Michael Kenna Ruth Bernard Apple Lisa & Apple Mac — The big decision in Jay's teaching career c.1984 Floppy disks “That mouse made all the difference in the world.” ← Click to Tweet The Original Apple Macintosh Adobe Photoshop 4.0 QuarkXPress 4.1 Aldus (later Adobe) Pagemaker Mac Draw Mac Write Matt Kushner, now an animator Sally Warner, now an oceanographer Prescott credits his time on the newspaper staff as his first true graphic design role Bluelines Guildscript, Columbia High School's literary magazine Columbia High School had the first computer graphics lab in the state of NJ Continuous Tone Print Jay's purpose-built studio above his garage Jay Seldin in his studio, surrounded by gear and his work In addition to printing, Jay also does mentoring/tutoring in his studio The principal activity is [still] teaching The workshop trips gained momentum slowly, with interest among friends ICP asked him to run programs It takes a year for Jay to put together a good workshop The Newark Museum Cuba Cultural Travel “When you go to a museum, there's no Cuban art. Because of the Embargo.” ← Click to Tweet Locally grown Cuban coffee The environmental footprint of coffee Cuban-American relations are approaching normal, whatever that means. The Cuban Free Internet, still to be determined Cuban Baseball League? Maybe. Cuba, The Accidental Eden, from PBS “Nature”, not the BBC The Royal Ballet in Cuba, from Channel4, not the BBC Jay and Not-So-Silent Bob on Facebook Tools Mac, printer, scanner — basically the same basic arrangement since the mid-1980s Epson Pro Stylus 9600 first large format 44″ wide-format printer Adobe Photoshop, even in Cuba A Map with marked locations of places to go 1966 Corvette Convertible Techniques Learn on your own, and then teach it to others Get a local “guide” who knows the area you're looking to photograph Gather ideas from your past students/attendees Habits Travel with someone who's part of the “system” as well as some who aren't Wake up early, have coffee, and read the [physical] paper Try Audible.com Free for 30-Days Visit BusyCreatorBook.com for your free trial Get On The Road by Jack Kerouac as a free audiobook Get The Episode Download The Busy Creator Podcast, episode 40(MP3, 54:45, 26.5 MB) Download The Busy Creator Podcast, episode 40(OGG, 54:45, 48.2 MB) Subscribe to The Busy Creator Podcast on iTunes

Interview NotesDrew Seldin stopped by Beyond The Mic to give listeners a deeper look into the inner workings of Project Triforce. Project Triforce does some of the most amazing and realistic gaming replicas in the industry. Drew shares the origins of the company as well as the creative process involved in bringing gaming’s iconic weaponry to life. We would like to thank Drew for taking MTR beyond the mic.LinksOfficial Site: http://www.projecttriforce.com/Twitter: http://www.twitter.com/projecttriforceFacebook: http://www.facebook.com/pages/Project-TriForce/249942738384135Youtube: http://www.youtube.com/user/projecttriforcetv?feature=results_mainListener InfoPlease take a moment and rate the show and/or app on iTunes.Follow My Take Radio on Twitter-@MyTakeRadioBecome a fan of My Take Radio on Facebook-Facebook.com/MyTakeRadioAdd My Take Radio to your circle on Google+Follow MTR on PinterestCheck out MyTakeRadioTV on YoutubeIf you have any feedback or questions you can now call the MTR Feedback line 347-815-0687.Guest inquiries can be forwarded to MTRHost@MyTakeRadio.comShow your support by picking up an MTR T-Shirt or by shopping from our Amazon store. 

A large part of my focus with The Trauma Therapist | Podcast has been supporting those therapists and the filmmakers who work with and/or help to heal military veterans. There have been a number of filmmakers and I take it as one of my goals to do what I can to support their work. Today I have as my guest Stephanie Seldin Howard, the Director and Producer of The Weight of Honor, a documentary about families caring for their catastrophically wounded loved ones returning from wars in Iraq and Afghanistan. Stephanie believes empathy is the driving force behind storytelling, something she attributes to her 25-year career as a broadcast news producer. The Omaha, Nebraska native is the recipient of a Los Angeles Emmy Award coupled with two additional Los Angeles Emmy nominations. Stephanie has produced specials and documentaries for CNN, Fox News Channel, and Reuters as well as local coverage for KNBC-TV and KTTV-TV in Los Angeles. In 2014 she was awarded the Roy W. Dean Grant awarded by From the Heart Productions, making her documentary The Weight of Honor possible. This is a pretty incredible documentary and the inside story about how the film was made is no less inspiring.Support this podcast at — https://redcircle.com/the-trauma-therapist-podcast-with-guy-macpherson-phd-inspiring-interviews-with-thought-leaders-in-the-field-of-trauma/donationsWant to advertise on this podcast? Go to https://redcircle.com/brands and sign up.